Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma Journal Article


Authors: Young, R. J.; Gupta, A.; Shah, A. D.; Graber, J. J.; Zhang, Z.; Shi, W.; Holodny, A. I.; Omuro, A. M. P.
Article Title: Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastoma
Abstract: Objective: To examine the potential utility of conventional MRI signs in differentiating pseudoprogression (PsP) from early progression (EP). Methods: This retrospective study reviewed initial postradiotherapy MRI scans of 321 patients with glioblastoma undergoing chemotherapy and radiotherapy. A total of 93 patients were found to have new or increased enhancing mass lesions, raising the possibility of PsP. Final diagnosis of PsP or EP was established upon review of surgical specimens from a second resection or by clinical and radiologic follow-up. A total of 11 MRI signs potentially helpful in the differentiation between PsP and EP were examined on the initial post-RT MRI and were correlated with the final diagnosis through χ or Fisher exact test. Results: Sixty-three (67.7%) of the 93 patients had EP, of which 22 (34.9%) were diagnosed by pathology. Thirty patients (32.3%) had PsP; 6 (16.7% of the 30) were diagnosed by pathology. Subependymal enhancement was predictive for EP (p = 0.001) with 38.1% sensitivity, 93.3% specificity, and 41.8% negative predictive value. The other 10 signs had no predictive value (p = 0.06-1.0). Conclusions: Conventional MRI signs have limited utility in diagnosing PsP in patients with recently treated glioblastomas and worsening enhancing lesions. We did not find a sign with a high negative predictive value for PsP that would have been the most useful for the clinical physician. When present, subependymal spread of the enhancing lesion is a useful MRI marker in identifying EP rather than PsP. © 2011 by AAN Enterprises, Inc. All rights reserved.
Journal Title: Neurology
Volume: 76
Issue: 22
ISSN: 0028-3878
Publisher: Lippincott Williams & Wilkins  
Date Published: 2011-05-31
Start Page: 1918
End Page: 1924
Language: English
DOI: 10.1212/WNL.0b013e31821d74e7
PROVIDER: scopus
PMCID: PMC3115805
PUBMED: 21624991
DOI/URL:
Notes: --- - "Export Date: 23 June 2011" - "CODEN: NEURA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Zhigang Zhang
    427 Zhang
  2. Weiji Shi
    121 Shi
  3. Robert J Young
    228 Young
  4. Antonio Marcilio Padula Omuro
    204 Omuro
  5. Jerome Jeffrey Graber
    24 Graber
  6. Akash Deelip Shah
    19 Shah
  7. Andrei Holodny
    206 Holodny
  8. Ajay Gupta
    6 Gupta